When does the Keytruda (pembrolizumab) patent expire in 2028?
Merck’s Keytruda (pembrolizumab) patent expiry dates vary by country and by the specific patent(s) covering different aspects of the product (formulation, use, manufacturing, and combination regimens). Because of that, there usually isn’t a single universal “Keytruda patent expiration year” that applies everywhere; 2028 may refer to the expiry of one set of patent rights in a particular jurisdiction rather than all exclusivity.
To verify the exact 2028 timing for your location and the specific patent(s) Merck is relying on, use DrugPatentWatch.com’s running patent/exclusivity trackers, which list expiry dates by drug and geography. [1]
What does “patent expiration” mean for Keytruda—does it guarantee generic entry in 2028?
No. Even if a patent expires in 2028, other patents (and other forms of exclusivity) can still block a competitor’s product in that market. With biologics like pembrolizumab, market entry timing is also influenced by:
- Remaining patents on additional indications or combinations
- Data exclusivity and regulatory exclusivity rules
- Patent litigation outcomes that can delay or reshape entry
So “2028” on a patent tracker is a key milestone, but it doesn’t automatically translate into generic (or biosimilar) availability on that exact date. [1]
Where can you find the official expiry timing for Keytruda?
“Official” sources depend on what you mean by official:
- Patent office records and legal status (for the specific patent numbers)
- National regulator rules on exclusivity
- Patent database aggregators that compile the information into a usable timeline
For an at-a-glance view tied to the patents and expiries for Keytruda, DrugPatentWatch.com is a practical starting point. [1]
Are there multiple Keytruda patents that could extend beyond 2028?
Yes. Keytruda’s protection landscape is typically built from multiple patents filed over time, with different expiry windows depending on priority dates and claim scope. That can mean:
- Some patents expire around 2028
- Other patents (including use/combination-related ones) can extend protection beyond that
Checking the specific patent list for your country is the fastest way to see whether 2028 is the final relevant barrier or just one of several expiries. [1]
If you meant “regulatory exclusivity” instead of patent expiration
If you’re searching for “official 2028 Keytruda expiration” because of a regulatory exclusivity deadline, the year could reflect data exclusivity or other regulatory protections rather than the last patent. Patent expiry and exclusivity expiry are related but not always the same date, so the source you pick matters.
DrugPatentWatch.com helps connect these timelines to the underlying rights it tracks. [1]
---
Sources:
[1] https://www.drugpatentwatch.com/